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Current diagnostic tests for Johne’s disease (JD), a chronic granulomatous inflammation
of the gastrointestinal tract of ruminants caused by Mycobacterium avium subspecies
paratuberculosis (MAP), lack the sensitivity to identify infected animals at early
(asymptomatic) stages of the disease. The objective was to determine the pattern of
MAP-associated dysbiosis of intestinal microbiota as a potential biomarker for early
detection of infected cattle. To that end, genomic DNA was extracted from ileal
mucosa and fecal samples collected from 28 MAP-positive and five control calves.
High-throughput Illumina sequencing of the V4 hypervariable region of the 16S rRNA
gene was used for community profiling of ileal mucosa-associated (MAM) or fecal
microbiota. The PERMANOVA analysis of unweighted UniFrac distances revealed distinct
clustering of ileal MAM (P = 0.049) and fecal microbiota (P = 0.068) in MAP-infected vs.
control cattle. Microbiota profile of MAP-infected animals was further investigated by
linear discriminant analysis effective size (LEfSe); several bacterial taxa within the phylum
Proteobacteria were overrepresented in ileal MAM of control calves. Moreover, based on
reconstructed metagenomes (PICRUSt) of ileal MAM, functional pathways associated
with MAP infection were inferred. Enrichment of lysine and histidine metabolism
pathways, and underrepresentation of glutathionemetabolism and leucine and isoleucine
degradation pathways in MAP-infected calves suggested potential contributions of ileal
MAM in development of intestinal inflammation. Finally, simultaneous overrepresentation
of families Planococcaceae and Paraprevotellaceae, as well as underrepresentation of
genera Faecalibacterium and Akkermansia in the fecal microbiota of infected cattle,
served as potential biomarker for identifying infected cattle during subclinical stages of
JD. Collectively, based on compositional and functional shifts in intestinal microbiota of
infected cattle, we inferred that this dynamic network of microorganisms had an active
role in intestinal homeostasis.
Keywords:Mycobacteriumavium subspecies paratuberculosis (MAP), Johne’s disease (JD),microbiota, dysbiosis,
gut inflammation
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INTRODUCTION
Mycobacterium avium subspecies paratuberculosis (MAP) is the
causative agent of Johne’s disease (JD), a chronic granulomatous
inflammation of the gastrointestinal (GI) tract in ruminants.
Numerous US and Canadian dairy herds are infected with
MAP with a prevalence ranging from 21 to 93% depending
on region and testing methods used to identify infected herds
(Losinger, 2005; Tiwari et al., 2006; Pillars et al., 2009). While
the high prevalence of MAP infection has imposed substantial
economic losses to the North American dairy and beef industries
(∼$79/cow/year for infected dairy herds; Losinger, 2005; Tiwari
et al., 2006; Pillars et al., 2009), it is also a public health
threat since several studies have indicated a potential association
between MAP and Crohn’s disease (CD) in humans (Scanu et al.,
2007; Mendoza et al., 2010).
Fecal–oral transmission is the primary mechanism of MAP
infection, with newborn calves apparently being most susceptible
(Windsor andWhittington, 2010). This initial infection is usually
followed by a prolonged (>2 years) incubation period (Over
et al., 2011), after which cattle exhibit clinical signs. Several
methods for detection of MAP have been developed, including
fecal culture and PCR, and serum/milk ELISA for detection of
MAP-specific antibodies. Although, sensitivity of these methods
is high for detection of infected cattle in later stages of disease,
sensitivity to detect MAP infection during its early subclinical
stages is low (Tiwari et al., 2006; Sorge et al., 2011). Therefore,
there is an immediate need to identify novel approaches for
early diagnosis of MAP in cattle. Recent advances in proteomics,
transcriptomics, and metabolomics have prompted a search for
potential biomarkers of CD (Jansson et al., 2009; Erickson et al.,
2012; Faubion et al., 2013), tuberculosis (Walzl et al., 2011),
and MAP (You et al., 2012; David et al., 2014; De Buck et al.,
2014). In addition, next-generation sequencing technologies and
metagenomics also have potential applications in biomarker
discovery. The composition of gut microbiota, a complex
network of microorganisms within virtually all vertebrates (Ley
et al., 2008), can be readily determined by variations in bacterial
16S rRNA gene sequences (Hooper et al., 2012). Furthermore,
inflammatory responses in the GI tract can disturb the normal
habitant of the resident microbiota and alter its composition and
functional properties (dysbiosis; Collins and Bercik, 2009); it is
noteworthy that the profile of these changes has been extensively
used for biomarker discovery for inflammatory bowel disease
(IBD) in humans (Berry and Reinisch, 2013).
It is well-established that proliferation of MAP in the ileal
mucosa and regional lymph nodes incites several cellular and
humoral immune responses (Over et al., 2011). Following
ingestion, MAP undergoes endocytosis by M cells of Peyer’s
patches and subsequently phagocytosis by macrophages, where
the bacteria resist intracellular degradation (by unknown
mechanisms), thereby inhibiting maturation of phagosomes
(Momotani et al., 1988; Weiss et al., 2006). Alternate immune
responses are then launched through a complex network
of cytokines and receptors, including CD4+ T cells and
cytolytic CD8+ T cells, which eventually lead to secretion of
proinflammatory cytokines, e.g., interferon-γ, tumor necrosis
factor alpha (TNF-α) and interleukin (IL) 2 (Coussens, 2001).
Consequently, microscopic and eventually macroscopic lesions
usually develop in the intestinal epithelium 1–3 months after
infection (Payne and Rankin, 1961; Buergelt et al., 1978).
However, there is a paucity of knowledge regarding impacts
of the aforementioned inflammatory responses on composition
and functional properties of intestinal microbiota. Therefore,
we hypothesized that due to modulatory interactions between
the host immune system and intestinal microbiota, microbial
dysbiosis occurs during subclinical stages of JD. Objectives were
to: (1) characterize the profile of MAP-associated microbial
dysbiosis in the ileal mucosa-associated microbiota (MAM)
and the fecal samples; and (2) determine whether the pattern
of fecal microbial dysbiosis was appropriate for detection of
subclinical JD. To those ends, dairy calves at various ages were
experimentally inoculated with either high or low doses of MAP
and infection subsequently confirmed by tissue culture. High-
throughput Illumina sequencing of the bacterial 16S rRNA genes
was used to characterize composition of microbial communities
and predict their functional properties (MAP-infected and
control calves).
MATERIALS AND METHODS
Animal Experiment
Details of the animal experiment and sampling procedures
have been reported (Mortier et al., 2013). In brief, Holstein–
Friesian bull calves (n = 56) were purchased from MAP-
free or low prevalence dairy farms across Alberta, Canada.
Inclusion criteria were based on negative pooled (n = 5) fecal
cultures (decontaminated and prepared for culture according
to manufacturer’s instructions; para-JEM R©, TREK Diagnostic
systems, Oakwood Village, OH, USA), and a within-herd
seroprevalence <5% (IDEXX Paratuberculosis Ab Test; IDEXX
Laboratories Inc., Westbrook, ME, USA) to minimize the risk of
including calves that had acquired intra-uterine MAP infection.
Calves were born on-farm, in the presence of a member of the
research team, to prevent contact with the dam or environment,
and then transferred to a biosecurity level 2 housing facility
with individual custom-built housing units. A virulent cattle type
MAP strain isolated from a clinical case, with an identical IS900—
RFLP profile as the reference strain K10 (data not shown)—
the recommended strain type to use in experimental infections
(Hines et al., 2007)—was grown in supplemented 7H9 broth and
used as inoculum. High dose (HD, 5 × 109 CFU) and low dose
(LD, 5 × 107 CFU) inoculums were prepared to be given on 2
consecutive days, corresponding to five times the recommended
standard bovine challenge dose (Hines et al., 2007) and 10 times
the lowest confirmed and consistent infectious dose for young
calves (Sweeney et al., 2006), respectively. The 56 calves were
randomly allocated to 5 age groups (2 weeks, and 3, 6, 9, and
12 months of age at the time of inoculation; n = 10 calves/age
group× 5 age group= 50) receiving eitherHD (n= 5 calves/dose
group/age group × 5 age group = 25) or LD (n = 25), and a
control group (n = 6). The experiment was conducted in two
blocks (2 consecutive experimental years) with the first 30 and
then 20 inoculated calves equally representing all age and dose
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FIGURE 1 | Summary of study design. The experiment was conducted in two replicates (consecutive experimental years) with first 30 and then 20 inoculated
calves equally representing all age and dose groups. Overall, 28 out of 50 inoculated calves were identified (indicated by bold numbers) as MAP-positive (based on
detection of at least one tissue culture positive, the “gold standard” for identification of MAP infection; Mortier et al., 2013), and along with five control calves were
selected for 16S rRNA profiling of the ileal mucosa-associated (MAM) and fecal micoribota.
groups, with three controls included in each block (Figure 1).
Animal care protocols M09083 and M09050 were approved by
the University of Calgary Animal Care Committee.
Necropsy, Tissue Culture, and Selection of
Animals for Microbiome Study
Following euthanasia (Euthanyl Forte R©, Bimeda-MTC Animal
Health Inc., Cambridge, ON, Canada) at 17 months of age,
necropsies were performed immediately on 21 tissue sites,
as described (Mortier et al., 2013). Macroscopic lesions were
assessed as: 0 = no macroscopic changes; 1 = 1 enlarged or
edematous lymph node (LN) of the small intestine or liver;
2 = multiple enlarged and edematous mesenteric LN and/or
hyperemia of the ileocaecal valve; 3 = enlarged mesenteric LN
and/or mild to moderate thickening of ileal or jejunal mucosa;
and 4 = enlarged mesenteric LN and severe thickening and
corrugation of the ileal, jejunal, and colon mucosa. Furthermore,
samples from the ileocaecal valve, ileocaecal LN, ileal LN and
distal ileum were subjected to histopathological examinations to
assess paratuberculosis-associated histological lesions as follows:
0 = no lesions; 1 = focal lesions; 2 =multifocal lesions; and 3 =
diffuse lymphocytic, multibacillary, or intermediate lesions.
From each of the 21 tissue sampling sites, a 2-g sample was
processed and cultured for identification of MAP-positive calves,
as described (Mortier et al., 2013). Tissue culture was considered
the gold standard in detection of MAP infection (Tiwari et al.,
2006); therefore, selection of MAP-inoculated calves to be
included in the current study was based on detection of at
least one tissue-positive site in that calf. Furthermore, control
calves identified as MAP-positive (based on tissue culture) were
excluded from downstream microbiome analysis.
Sample Processing, DNA Extraction, and
Quality Check
Genomic DNA was extracted from ileal MAM and fecal
microbiota. Frozen distal-ileum tissue samples were thawed at
4◦C overnight. Tissue samples were then rinsed carefully with
sterile PBS and the mucosa associated-layer was obtained by
scraping with a sterile scalpel blade. For each sample, 100mg
was used for extraction of bacterial genomic DNA using ZR-
96 Tissue and Insect DNA Kit (Zymo Research, Irvine, CA,
USA). Fecal samples were collected from the distal colon;
30 g of each sample was carefully homogenized cryogenically
using Geno/Grinder R© 2010 (SPEX SamplePrep, Metuchen, NJ,
USA) and DNA extracted using a ZR-96 Fecal DNAKit (Zymo
Research, Irvine, CA, USA). Both extraction kits included a bead-
beating step using the ZR BashingBead racks (Zymo Research,
Irvine, CA, USA) for mechanical lysis of the cells. Thereafter,
DNA was quantified using a NanoDrop 2000 spectrophotometer
(Thermo Scientific, Waltham, MA, USA). The DNA samples
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were normalized to 20 ng/µl, and quality verified by PCR
amplification of the 16S rRNA gene using universal primers
27F (5′-GAAGAGTTTGATCATGGCTCAG-3′) and 342R (5′-
CTGCTGCCTCCCGTAG-3′), as described (Khafipour et al.,
2009). Amplicons were verified by agarose gel electrophoresis.
Library Construction and Illumina
Sequencing
The PCR amplification was targeted to amplify the V4 region of
16S rRNA gene using modified F515/R806 primers (Caporaso
et al., 2012) as described (Derakhshani et al., 2016). The
reverse PCR primer was indexed with 12-base Golay barcodes,
allowing for multiplexing of samples. For each sample, the PCR
reaction was performed in duplicate and contained 1.0 µl of
pre-normalized DNA, 1.0 µl of each forward and reverse primer
(10 µM), 12 µl HPLC grade water (Fisher Scientific, Ottawa,
ON, Canada), and 10 µl of 5 Prime Hot MasterMix (5 Prime
Inc., Gaithersburg, MD, USA). Reactions consisted of an initial
denaturing step at 94◦C for 3 min followed by 35 amplification
cycles at 94◦C for 45 s, 50◦C for 60 s, and 72◦C for 90 s, with
a final extension step at 72◦C for 10 min in an Eppendorf
Mastercycler pro (Eppendorf, Hamburg, Germany). Then, PCR
products were purified using a ZR-96 DNA Clean-up Kit (ZYMO
Research, Irvine, CA, USA) to remove primers, dNTPs, and
reaction components. The V4 library was then generated by
pooling 200 ng of each sample, quantified by Picogreen dsDNA
(Invitrogen, Burlington, ON, Canada). This was followed by
multiple dilution steps using pre-chilled hybridization buffer
(HT1; Illumina, San Diego, CA, USA) to bring the pooled
amplicons to a final concentration of 5 pM, as determined
with a Qubit 2.0 Fluorometer (Life Technologies, Burlington,
ON, Canada). Finally, 15% of the PhiX control library was
spiked into the amplicon pool to improve the unbalanced and
biased base composition, a common characteristic of low-
diversity 16S rRNA libraries. Customized sequencing primers for
read1 (5′-TATGGTAATTGTGTGCCAGCMGCCGCGGTAA-
3′), read2 (5′-AGTCAGTCAGCCGGACTACHVGGGTWTCTA
AT-3′), and index read (5′-ATTAGAWACCCBDGTAGTCC
GGCTGACTGACT-3′) were synthesized and purified
by polyacrylamide gel electrophoresis (Integrated DNA
Technologies, Coralville, IA, USA) and added to the MiSeq
Reagent Kit v2 (300-cycle; Illumina, San Diego, CA, USA).
The 150 paired-end sequencing reaction was performed on a
MiSeq platform (Illumina) at the Gut Microbiome and Large
Animal Biosecurity Laboratories, Department of Animal Science,
University of Manitoba, Winnipeg, MB, Canada. The sequencing
data were deposited into the Sequence Read Archive (SRA) of
NCBI (http://www.ncbi.nlm.nih.gov/sra) and can be accessed via
accession number SRR2181770.
Bioinformatic Analyses
The PANDAseq assembler (Masella et al., 2012) was used to
merge and fix overlapping paired-end Illumina fastq files. All
sequences withmismatches or ambiguous calls in the overlapping
region were discarded. The output fastq file was analyzed by
downstream computational pipelines of the open source software
package QIIME (Caporaso et al., 2010b). Assembled reads were
de-multiplexed according to barcode sequences; those with a
read length<175 bases were removed from downstream analysis.
Chimeric reads were filtered using UCHIME (Edgar et al., 2011)
and sequences were assigned to Operational Taxonomic Units
(OTU) using the QIIME implementation of UCLUST (Edgar,
2010) at 97% pairwise identity threshold. Taxonomies were
assigned to the representative sequence of each OTU using RDP
classifier (Wang et al., 2007) and aligned with the Greengenes
Core reference database (DeSantis et al., 2006) using PyNAST
algorithms (Caporaso et al., 2010a). A phylogenetic tree was built
with FastTree 2.1.3. (Price et al., 2010) for further comparisons
between microbial communities.
Within community diversity (α-diversity) was calculated
using QIIME default scripts. Even depths of 12,000 and
16,000 sequences per sample were used for calculation of
Chao1 richness and Shannon and Simpson diversity indices
for the ileal MAM and fecal microbiota of MAP-infected
and control, respectively (Figure 2). Alpha-diversity indices
were also calculated according to the inflammation status
(comparison between non-inflamed calves and inflamed ones—
calves with minimum score of 1 for both macroscopic lesions
and histologic scores), dose or age of infection (Table S1). To
compare microbiota composition between samples, β-diversity
was measured by calculating phylogenetic-based unweighted
UniFrac distances (Lozupone and Knight, 2005). Principal
coordinate analysis (PCoA) was applied on resulting distance
matrices to generate two-dimensional plots using default settings
of the PRIMER-6 (Figure 3; Warwick and Clarke, 2006). Finally,
open source software PICRUSt (phylogenetic investigation of
communities by reconstruction of unobserved states; Langille
et al., 2013) was used to predict functional genes of the classified
members of ileal MAM (resulting from reference-based OTU
picking against Greengenes database). Predicted genes were then
hierarchically clustered and categorized under KEGG (Kanehisa
and Goto, 2000) orthologs (KOs) and pathways (level 1–3;
Table S2).
Statistical Analyses
The UNIVARIATE procedure of SAS (SAS 9.3, 2012) was used
to test the normality of residuals for α-diversity measurements
(Table S1). Non-normally distributed data were subjected to box-
cox power transformation and then used to assess effects of MAP
infection, using MIXED procedure of SAS. The null hypotheses
being tested were: (a) the diversity of the ileal MAM and fecal
microbiota of MAP-infected calves (based on detection of at
least one positive tissue culture) are similar to control group, (b)
the diversity of the ileal MAM and fecal microbiota of calves
challenged with either high or low doses of MAP at 5 ages
are similar; and (c) the diversity of the ileal MAM and fecal
microbiota of inflamed calves (all calves with minimum score of
1 for both macroscopic lesions and histologic inflammation) are
similar to non-inflamed ones. The effect of block (experimental
year) was treated as a random factor in all comparisons. When
normality was not achieved, GLIMMIX procedure of SAS was
employed to fit Poisson or negative binomial distributions
using a log-link function. The goodness-of-fit criteria for each
distribution was compared using the−2 log likelihood (smaller is
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FIGURE 2 | Graphic summary of alpha-diversity indices. Comparison of Chao1, Shannon, and Simpson indices of (A) fecal microbiota, and (B) ileal
mucosa-associated microbiota (MAM) between MAP-infected and control animals. Statistical analyses were conducted based on PROCMIXED procedure of SAS.
The null hypotheses being tested was that the mean of diversity indices of the ileal MAM and the fecal microbiota of infected calves are similar to control group. P
<0.05 were considered significant. Trends were discussed at P < 0.1.
FIGURE 3 | Principal coordinates analysis (PCoA) of unweighted UniFrac distances. Between community diversity was tested for impact of MAP infection on
clustering patterns of microbiota in (A) feces (P = 0.068), and (B) ileal mucosa (P = 0.049). Triangles represent samples belonging to calves that were included in the
first year of the infection trial, whereas circles represent samples that belong to the second year. Green and red indicate samples obtained from control and
MAP-infected calves, respectively. The impact of MAP infection and sampling year on the clustering pattern of microbial communities were tested using PERMANOVA
(implemented in PRIMER-6 software). PERMDIS test was performed to test the null hypothesis of homogeneity of dispersions. P < 0.05 were considered significant.
better), Akaike information criterion (AIC; smaller is better), and
Pearson’s Chi-square over degrees of freedom (DF) ratio (closer
to 1 is better). All pairwise comparisons among the groups were
tested using Tukey’s studentized range adjustment.
Permutational multivariate analysis of variance
(PERMANOVA: a FORTRAN computer program for
permutational multivariate analysis of variance. Department of
Statistics, University of Auckland, New Zealand) implemented
in Primer6 software was used to detect significant differences
between β-diversity measures of microbial communities. Label
permutations were used in PERMANOVA to estimate the
distribution of test statistics under the null hypothesis that
within-group UniFrac distances are not significantly different
from between-group distances (Kuczynski et al., 2010). Infection
status (infected vs. control) was considered as a fixed factor
whereas the effect of block (experimental year) was treated
as random factor in all comparisons. Because PERMANOVA
analysis makes the implicit assumption (similar to ANOVA) that
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dispersions are roughly constant across treatments, PERMDISP
test (implemented in Primer-6 software) was performed to check
the homogeneity of multivariate dispersions within treatments
using phylogenetic-based unweighted UniFrac distances of
microbial communities (Figure 3). The PERMDISP test is
analogous to PROC UNIVARIATE used above for testing the
homogeneity of residuals prior to fitting in ANOVAmodels.
Statistical analyses regarding relative abundances of bacterial
taxa at different phylogenetic levels between MAP-infected
and control calves were performed using Linear Discriminant
Analysis Effective Size (LEfSe; Segata et al., 2011), software
principally developed to discover metagenomics biomarkers.
This included the non-parametric factorial Kruskal–Wallis (KW)
sum rank test (Kruskal and Wallis, 1952) to test whether the
values (the relative abundances of the OTUs summarized at the
genus level) in different classes (MAP-infected vs. control) were
differentially distributed, then the pairwise Wilcoxon test was
used to determine whether all pairwise comparisons between
subclasses (experimental years 1 and 2) within different classes
agreed with the class level trend. Finally, linear discriminant
analysis (LDA) was done to estimate the effect size of each
differentially abundant feature. The threshold on the logarithmic
LDA score for discriminative features was set at 2.0, so that
features with at least 2.0 log-fold changes were considered
significant (Figures 4, 7). The relative abundances of the genera
showing the highest LDA scores (revealed by LEfSe analysis)
were entered into a logistic regression model and their ability
to discriminate group classification was evaluated using area
under the receiver operator characteristic (ROC) curve (Figure 5;
Delong et al., 1988).
Finally, the relationship between abundant (>1% of
community) ileal MAM and histopathological parameters was
explored using non-parametric Spearman’s rank correlation
coefficient test implemented in PAST software (Hammer et al.,
2012) and the resulting correlation matrix was visualized in
a heatmap format generated by the corrplot package of R
(Corrplot: visualization of a correlation matrix. R package
version 02-0. 2010. [http://CRAN]). For each correlation,
the correlation coefficient (Spearman’s ρ) and P-value were
obtained. The correlation coefficient values ranged from −1 to
+1 with larger absolute values indicating stronger relationship
while positive and negative values indicating the direction of
association.
For all comparisons, statistical significance was considered at
a P < 0.05. Trends were discussed at P < 0.10. P-values for
fixed effect [P(infection)], random effect [P(year)], and homogeneity
of multivariate dispersion [P(PERMDISP)] were calculated and
presented separately.
RESULTS
Selection of Animals Based on Tissue
Culture Results
As previously reported (Mortier et al., 2013), based on culture
of all 21 tissue sites for individual animals, 28 of the 50 MAP-
inoculated calves were identified with at least one MAP-positive
tissue. In addition, one of the six control calves hadMAP-positive
tissue sites, and thus was excluded from this study. In total, 28
MAP-positive and five control calves were selected for 16S rRNA
profiling of ileal MAM and fecal microbiota (Figure 1).
Diversity Analyses of Microbial
Communities
Illumina paired-end sequencing of ileal MAM and fecal
microbiota generated an average of 29,370 and 41,086 high-
quality sequences per sample, respectively, with a median
sequencing length of 253 nt covering the full length of the V4
hypervariable region of the 16S rRNA gene. At an even depth
of 16,000 and 12,000 sequences per sample, clustering of OTUs
at 97% similarity threshold resulted in Good’s non-parametric
coverage estimates (Good, 1953) of 97.35 and 99.45% for fecal
and ileal MAM, respectively. In general, comparing the Chao1
richness and Shannon and Simpson diversity indices within
each sampling site revealed no apparent significant differences
between MAP-infected and control animals although some
trends were observed (Figure 2). Similar results were observed
with regards to inflammation status (comparison between non-
inflamed calves and inflamed ones—calves with minimum score
of 1 for both macroscopic lesions and histologic scores), dose or
age of infection (Table S1).
Furthermore, PERMANOVA analyses of unweighted UniFrac
distances revealed that fecal microbiota of MAP-infected animals
tended to cluster separate from control group [P(infection) = 0.068
and P(PERMDISP) = 0.733; Figure 3A]. In addition, there was
a distinct clustering pattern between ileal MAM [P(infection) =
0.049 and P(PERMDISP) = 0.448] of infected and control animals
(Figure 3B). For both sampling sites, the impact of block
(sampling year) on composition of bacterial communities was
significant [P(year) < 0.001; Figures 3A,B].
Taxonomic Classification of 16S rRNA
Gene Sequences
Alignment of OTUs at 97% similarity threshold against
Greengenes database resulted in identification of 29 and 14
bacterial phyla, and 489 and 244 bacterial genera within the
ileal MAM and fecal microbiota, respectively. While majority of
OTUs were identified at genus (g.) or species levels, some were
only classified at the phylum (p.), class (c.), order (o.), or family
(f.). Proportions of the abundant (>1% of community) bacterial
phyla and genera have been presented in Table 1. Proportions of
the most abundant representative OTUs (>1% of community) in
MAP-infected vs. control calves, regardless of significance, were
depicted in Figure S1.
Utilizing Fecal and Ileal MAM Microbiota
Profile for Distinguishing between
MAP-Infected and Control Animals
Overrepresentation of bacterial taxa—at different taxonomic
levels—in response to MAP-infection were further characterized
using LEfSe analysis (Figure 4). In fecal microbiota, the
proportion of members of the p. Verrucomicrobia (including g.
Akkermansia), and p. Firmicutes (including g. Faecalibacterium)
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FIGURE 4 | Phylogenetic comparisons of ileal mucosa-associated (MAM) and fecal microbiota in control and MAP-infected animals. LEfSe was used to
determine differentially abundant genera in (A) fecal microbiota, and (B) ileal MAM of MAP-infected and control animals. Color code represents the class of treatment
(red indicates variables that were significantly enriched in response to MAP infection, whereas green indicates variables that were significantly enriched in the control
group).
FIGURE 5 | Disease classification based on microbiome profile and histopathology scores. Receiver operating characteristics (ROC) curves and area under
the curve (AUC) values with 95% confidence intervals in parentheses comparing MAP-infected and control animals based on (A) fecal microbiota profile, and (B) ileal
mucosa-associated microbiota (MAM) profile, histopathology scores, and combination of ileal MAM profile and histopathology scores. The straight line represents the
null model.
were higher in control calves, whereas the proportion of the
unclassified Planococcaceae (p. Firmicutes) and g. CF231 (p.
Bacteroidetes) enriched in MAP-infected calves (Figure 4A
and Figure S2). The relative abundances of the OTUs aligned
to these four bacterial genera significantly differentiated
the fecal microbiota of MAP-infected and control animals
(AUC = 0.985, P < 0.001, Figure 5A). Conversely, several
members of the p. Proteobacteria were relatively more
abundant in the ileal MAM of controls compared to MAP-
infected calves (Figure 4B). These included members of the
c. Alphaproteobacteria (including f. Sphingomonadaceae),
c. Gammaproteobacteria (including unclassified members
of f. Pseudomonadaceae). Within the phylum Firmicutes,
g. Lactobacillus and Epulopiscium were overrepresented in
the ileum of control calves, whereas the proportion of the
unclassified members of the f. Mogibacteriaceae (p. Firmicutes)
were increased in MAP-infected calves. The relative abundances
of the OTUs aligned to Lactobacillus, Epulopiscium, unclassified
members of Pseudomonadaceae, and Mogibacteriaceae
significantly differentiated the MAP-infected and control
animals (AUC = 0.976, P < 0.001, Figure 5B). In addition, a
combination of ileal MAMmicrobiota profile and histopathology
scores (macroscopic and histological lesions) showed increased
discriminative power over the use of microbiota profile alone
(AUC= 0.992, P < 0.001, Figure 5B).
Correlation between Mucosa-Associated
Microbiota and Histopathology Parameters
There were significant correlations between the ileal MAM and
occurrence of macroscopic and histological lesions. Within the
p. Firmicutes, members of the g. Clostridium (Spearman’s ρ =
+0.48 and P = 0.008) and Turicibacter (Spearman’s ρ =
+0.46 and P = 0.012), and f. Peptostreptococcaceae (Spearman’s
ρ = +0.42 and P < 0.022) had strong positive correlations
with severity of histological lesions, whereas g. Pseudomonas
(within p. Proteobacteria) were negatively correlated (Spearman’s
ρ = −0.38 and P = 0.041) with severity. The g. Lysinibacillus
(p. Firmicutes) were the only member of the ileal MAM
positively correlated (Spearman’s ρ = +0.42 and P = 0.023)
with occurrence and severity of macroscopic lesions. Exploring
co-occurrence of the g. Mycobacterium with other abundant
members of the ileal MAM also suggested a strong negative
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FIGURE 6 | Spearman’s correlation coefficient analysis. The correlation matrix was based on the relationship of the abundant ileal mucosa-associated bacterial
genera (>0.1% of community) with the severity of macroscopic and histological lesions. The strength of the correlation between each pair of variables is indicated by
the size and color intensity of the squares. A color code of dark blue indicates a positive correlation coefficient close to +1, whereas dark red indicates a negative
correlation coefficient close to –1. All pairwise correlations with a P < 0.05 were considered significant and indicated by “*”. The last row of the matrix was included to
explore the correlation between the proportion of genus Mycobacterium and other abundant members of the mucosa-associated microbiota (MAM).
correlation between members of this genus and those of the g.
Streptococcus (p. Firmicutes; Figure 6).
Alterations in Functional Properties of
Microbiota in Response to MAP-Infection
The reference-based OTU picking resulted in 80.03% of the
sequencing reads being mapped to the Greengenes database.
Consequently, a high proportion of MAM were utilized for
metagenomic predictions. Major KEGG pathways including
valine, leucine, and isoleucine degradation, as well as glutathione
and tryptophan metabolism exhibited more than 2.5 log-fold
increase within the ileal MAM of control calves, whereas
the proportion of fatty acid, lysine, thiamine, and histidine
metabolism pathways were enriched in the ileal MAM of the
MAP-infected group (Figure 7).
DISCUSSION
The present study was the first attempt to characterize
microbial dysbiosis following MAP-induced GI inflammation.
Notwithstanding, characteristics of gut microbiota dysbiosis,
including general pattern and indicator taxa, have been
investigated as potential biomarkers for detection/prediction
of chronic gut inflammatory diseases (Berry and Reinisch,
2013). Exploring global shifts in the composition of the ileal
MAM and fecal microbiota of infected cattle identified several
microbial fingerprints with potential applications for tracking
JD during subclinical asymptomatic stages. Additionally, the
reconstructed metagenomics approach (PICRUSt) used in the
current study revealed changes in the functional properties of the
ilealMAM afterMAP infection, suggesting potential roles for this
dynamic network ofmicroorganisms in pathogenesis of intestinal
inflammation.
Experimentally infected calves in this study were exposed
to either high or low doses of viable MAP, which corresponds
to the range of doses that calves would be exposed to under
natural conditions on farm. Therefore, we inferred that the
outcomes were more relevant for clinical use. Although the
success rate for experimental induction of MAP infection
varies greatly and results are prone to errors produced by low
sensitivity of current tests (Hines et al., 2007), the combination of
methods used for identification of MAP-positive calves [positive
interferon-gamma release assay (Mortier et al., 2014c), fecal
shedding (Mortier et al., 2014b), antibody ELISA (Mortier et al.,
2014a), and MAP culture of intestinal tissues along with gross
and histopathological lesion scoring (Mortier et al., 2013)]
demonstrated a high success rate of exposure and infection in
these inoculated calves. However, inclusion criteria for defining
MAP-infected and control calves for the purpose of this study,
were based on stringent criteria of presence and absence of
tissue-culture positive sites, commonly accepted as the gold
standard for identification of MAP-infected animals (Tiwari
et al., 2006).
The ileal MAM and fecal microbiota of inflamed and
non-inflamed calves (based on macroscopic or histologic
inflammatory responses) did not differ in richness and
biodiversity of microbial communities (Table S1). Although, this
trend has not always been consistent (Lepage et al., 2005), an
overall decrease of microbial diversity and stability has been
generally reported in subjects with chronic GI inflammation
(Willing et al., 2010; Michail et al., 2012). The majority of
these studies were based on the comparison between control
subjects with those at clinical stages of IBD; therefore, we
speculate that the unchanged biodiversity of intestinal microbiota
Frontiers in Microbiology | www.frontiersin.org 8 March 2016 | Volume 7 | Article 426
Derakhshani et al. Gut Microbiome in MAP Infection
FIGURE 7 | Differentiation of functional metagenomes of ileal mucosa (MAM) and fecal microbiota in control and MAP-infected calves. A Statistical
differences between KEGG pathways (explored at Levels 1–3, indicated as L1–L3) of ileal MAM metagenomes were evaluated by LEfSe, a metagenome analysis
approach which performed the linear discriminant analysis following the Wilcoxon Mann–Whitney test to assess effect size of each differentially abundant variable. The
length of the horizontal bars indicated log-fold changes for each variable. Color code represents the class of treatment (red indicates variables that were significantly
altered in response to MAP infection, whereas green indicates variables that were significantly associated with the control group).
ofMAP-infected calves in the current study (Figure 2) was due to
a lack of severe inflammatory responses during subclinical stages
of JD.
Comparison of unweighted UniFrac distances of microbial
communities revealed distinct clustering patterns of the ileal
MAM and fecal microbiota in MAP-infected vs. control
calves (Figure 3). The effect of sampling year was the most
discriminative factor in clustering patterns of both mucosa
and fecal microbial communities; most likely this was due to
differences in ambient temperature at sampling (summer vs.
winter in Years 1 and 2, respectively) or dietary factors that
impacted microbiota composition. By considering experimental
year as a random factor in PERMANOVA analysis, impacts
of infection on the composition of the ileal MAM and fecal
microbiota were significant.
Previous studies have reported the occurrence of the so-called
“microbial dysbiosis” in feces (Joossens et al., 2011) and intestinal
mucosa (Walker et al., 2011) of IBD patients, which can co-occur
with gastrointestinal inflammation and result in compromised
interaction between the host immune system and microbiota
(Hooper et al., 2012). Colonization and replication of MAP
within intestinal mucosa, considered the first sign of infection,
can occur as early as 1 month post exposure (Whittington and
Sergeant, 2001). As reported (Mortier et al., 2013), in the current
study, macroscopic and histologic lesions were detected in 62 and
84% of inoculated animals, respectively. In a parallel study to this
work, evaluation of transcripts in whole blood samples revealed
that at 3 months post infection, IL-6 signal transducer (ST) gene
was upregulated in the MAP-infected calves compared to the
control group (David et al., 2014). The IL6ST/gp 130 is known
to regulate transduction of proinflammatory cytokines, i.e.,
IL-6 and IL-27 (Silver and Hunter, 2010), which their increased
production has been reported in CD patients with chronic
colitis (Yamamoto et al., 2000; Lovato et al., 2003). These data
together suggest development of a chronic inflammation in the
GI tract of infected calves, which could have promoted microbial
dysbiosis. The presence of dysbiosis was further confirmed by
obtaining high AUC values (>0.97; Figure 5B) when using
a combination of microbiome profile and histopathology
scores, or microbiome profile alone, to differentiate between
MAP-infected and control calves. The logistic model used for
this purpose included OTUs belonging to genera Lactobacillus
and Epulopiscium (overrepresented in the ileal MAM of control
calves), as well as unclassifiedmembers of the f. Mogibacteriaceae
(enriched in the ileal MAM of MAP-infected calves); unraveling
their contribution in development of MAP-specific microbial
dysbiosis.
There were positive correlations between members of
g. Clostridium and f. Peptostreptococcaceae with histopathology
scores, whereas g. Pseudomonas was negatively correlated
to tissue inflammation (Figure 6). Although the role of
f. Peptostreptococcaceae and g. Pseudomonas in development
of mucosal inflammation is poorly understood, commensal
species within the g. Clostridium can modulate inflammatory
responses in intestinal mucosa by stimulating expression of
Treg cells (Atarashi et al., 2011). The positive correlation of
g. Clostridium with histopathology scores in the current study
might have be either due to the specific characteristics of
microbiota-host immune interaction in ruminant, or more
likely due to the lack of resolution of 16S rRNA gene
sequencing methodology in differentiating several strains within
this bacterial lineage. Clostridium difficile is one of the pathogens
belonging to this genus that produces inflammatory enterotoxins
(Pothoulakis and Lamont, 2001) and has been associated
with IBD (Rodemann et al., 2007). Therefore, care should
be taken when making inferences about disease pathogenesis
based on compositional changes of microbiota based on 16S
rRNA profiling.
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TABLE 1 | Relative abundances of abundant (>1% of community) bacterial
phyla and genera in control and MAP-infected samples.
Phylum Genus Proportion (%) ± SDa
Control MAP-positive
FECAL MICROBIOTA
Bacteroidetes 11.10±5.20 16.81± 6.11
Uncl. Bacteroidales 1.38±0.94 4.89± 3.84
Uncl. Bacteroidaceae 0.76±0.61 3.40± 4.23
Uncl. Rikenellaceae 3.49±3.72 1.63± 1.43
Uncl. S24-7 0.92±1.06 1.67± 1.25
5-7N15 3.45±2.04 3.31± 1.79
Firmicutes 80.25±3.27 78.03± 6.19
Clostridium 1.96±0.63 2.04± 0.42
Uncl. Clostridiaceae 9.38±4.52 6.96± 3.11
Uncl. Clostridiales 15.93±3.24 14.53± 2.70
Dorea 1.69±2.30 0.96± 0.45
Uncl. Lachnospiraceae 2.33±1.17 2.41± 0.93
Uncl. Mogibacteriaceae 1.26±0.67 1.12± 0.34
Uncl. Peptostreptococcaceae 10.86±6.77 8.26± 4.04
Ruminococcus 1.41±0.84 1.33± 0.64
Uncl. Ruminococcaceae 27.71±7.38 32.93± 7.46
SMB53 1.11±0.43 0.87± 0.37
Turicibacter 1.40±1.19 1.86± 1.17
Proteobacteria 1.79±3.74 0.34± 0.40
Sphingomonas 1.63±3.64 0
Tenericutes 1.98±1.02 2.99± 1.01
Uncl. RF39 1.82±0.97 2.68± 1.02
Verrucomicrobia 3.56±4.04 0.57± 0.71
Akkermansia 3.55±4.05 0.57± 0.71
ILEAL MUCOSA-ASSOCIATED MICROBIOTA
Actinobacteria 2.27±0.81 3.38± 4.85
Bifidobacterium 0.85±0.84 1.00± 0.95
Bacteroidetes 16.73±8.51 14.55± 736
Bacteroides 3.51±1.81 3.07± 1.60
Uncl. Bacteroidales 3.96±2.23 3.05± 1.84
Porphyromonadaceae 2.00±1.06 1.50± 0.95
Prevotella 3.82±2.31 3.61± 2.15
Uncl. S24-7 1.26±0.71 1.15± 0.78
Chloroflexi 1.48±0.94 0.79± 0.52
Cyanobacteria 1.67±2.60 0.70± 0.85
Uncl. Streptophyta 1.13±2.53 0.14± 0.60
Firmicutes 56.33±12.34 64.96± 14.16
Allobaculum 1.44±0.76 1.09± 0.67
Blautia 2.97±2.40 1.98± 1.11
Butyrivibrio 1.46±1.13 1.10± 0.78
Clostridium 2.30±1.19 2.91± 3.27
Uncl. Clostridiales 6.57±1.02 9.46± 4.27
Uncl. Clostridiaceae 8.30±7.91 9.76± 6.01
Coprococcus 2.27±1.49 1.49± 0.98
Epulopiscium 5.67±1.28 3.27± 1.82
Lactobacillus 1.74±0.85 0.82± 0.45
Uncl. Lachnospiraceae 2.28±1.19 1.92± 1.08
Uncl. Peptostreptococcaceae 8.76±9.81 13.99± 9.90
(Continued)
TABLE 1 | Continued
Phylum Genus Proportion (%) ± SDa
Control MAP-positive
Uncl. Ruminococcaceae 3.49± 1.13 4.76± 3.16
Ruminococcus 2.67± 1.32 2.52± 1.01
Turicibacter 1.26± 1.87 2.44± 2.33
Proteobacteria 17.10± 3.59 10.41± 5.63
Campylobacter 1.17± 0.77 0.68± 0.52
Uncl. Helicobacteraceae 1.99± 1.26 1.29± 1.09
Pseudomonas 4.30± 2.41 3.20± 2.09
Uncl. Xanthomonadaceae 1.03± 0.53 0.57± 0.38
Tenericutes 0.79± 0.45 2.46± 2.10
Uncl. RF39 0.69± 0.45 2.30± 2.10
aSD: Standard deviation of the mean.
Based on predicted metagenomes (PICRUSt) of the ileal
MAM, we inferred that there were several functional pathways
associated with MAP infection (Figure 7). An interesting
characteristic of inflammation-associated dysbiosis is the ability
of certain bacteria to utilize host substrates to gain a fitness
advantage during inflammation (Rooks et al., 2014). In the
current study, genes encoding amino acid metabolism pathways
of histidine and lysine were more abundant in the MAM
of MAP-infected calves, whereas concurrently, there was an
underrepresentation of degradation pathways for valine, leucine,
and isoleucine, as well as glutathione and tryptophanmetabolism
pathways. Biosynthesis of glutathione, by members of p.
Proteobacteria and few streptococci and enterococci strains,
contributes to maintain bacterial homeostasis during oxidative
stress caused by inflammation (Sherrill and Fahey, 1998; Morgan
et al., 2012). Furthermore, underrepresentation of glutathione
metabolism pathways of MAP-infected calves corresponded well
to the decreased proportion of the members of p. Proteobacteria
in the ileal MAM of infected animals. This could have been
due to unfavorable growth conditions in inflamed mucus for
this bacteria lineage, which, in turn, might have resulted in
impaired ability of microbiota of infected calves to maintain
homeostasis. Lending support to the abovementioned findings,
De Buck et al. (2014) in a parallel study to this experiment
reported increased concentrations of branched chain amino acids
leucine and isoleucine in the serum of the MAP-infected calves.
Likewise, enrichment of histidine metabolism pathways in the
ileal MAM of infected calves also corresponded to the increased
serum concentrations of this amino acid in the same group of
calves (De Buck et al., 2014). Collectively, these results suggest
that dysbiosis is not simply limited to compositional changes in
intestinal microbiota, but rather it includes major impairments
in fundamental microbial metabolic functions that can affect the
physiology of host animal and alters its metabolomic profile.
Since the composition and diversity of small intestine
microbiota differs from fecal microbiota (Marteau et al., 2001;
Lepage et al., 2005) and the application of the latter, due to
non-invasive sample procurement, is preferred for biomarker
discovery, characteristics of MAP-associated dysbiosis of fecal
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microbiota were further investigated (Figures 4A, 5A). The
combined logistic model used for distinguishing the fecal
microbiota of MAP-infected animals from the control group was
based on the relative abundances of the OTUs that are aligned
to f. Planococcaceae and Paraprevotellaceae (overrepresented in
MAP-infected fecal microbiota), as well as g. Faecalibacterium
and Akkermansia (underrepresented in MAP-infected fecal
microbiota). Fitting the collection of these OTUs in the
logistic model resulted in high AUC value (0.985), suggesting
their potential to serve as biomarker for identifying infected
cattle during subclinical stages of JD. Underrepresentation of
g. Akkermansia and Faecalibacterium in the fecal microbiota
of infected calves was in agreement with the trend seen in
IBD patients (Berry and Reinisch, 2013). Members of the
g. Faecalibacterium are sensitive to inflammatory changes in
intestinal ecosystem (Berry and Reinisch, 2013), most likely due
to changes in concentration of metabolites (i.e., increased bile
acid concentration) or increased reactive oxygen stress (Jansson
et al., 2009; Morgan et al., 2012), which could make them ideal
biomarkers of GI inflammation. Moreover, underrepresentation
of the g. Akkermansia in fecal microbiota of MAP-infected
calves could also be indicative of intestinal inflammation.
Following chronic inflammation, the overall abundance of
mucolytic bacteria usually increases in the mucus layer of
the IBD patients; however, inflammatory-associated changes
in mucin composition predispose to overgrowth of specific
mucolytic species within g. Ruminococcus (Png et al., 2010;
Berry and Reinisch, 2013). Consequently, the proportion of the
g. Akkermansia, a dominant and native mucin degrader of the
intestinal mucosa, has been reported to be higher in healthy
subjects (Berry and Reinisch, 2013).
CONCLUSIONS
Our metagenomics approach identified microbes and
microbial functions associated with MAP infection. Based
on compositional and predicted functional shifts in the ileal
MAM, we inferred that this dynamic network of microorganisms
has a potential role in development of intestinal inflammation
following MAP infection. Furthermore, microbiota composition
of the feces of infected calves had promised as biomarker
candidates for differential diagnosis of JD during subclinical
stages of the disease. Simultaneous overrepresentation of f.
Planococcaceae and Paraprevotellaceae and underrepresentation
of g. Faecalibacterium and Akkermansia in the fecal microbiota
of infected cattle could serve as indicators of MAP infection.
Notwithstanding, the sensitivity and specificity of these markers
to detect MAP infection under field conditions need to be
validated in large-scale field studies.
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